340B drug discounts only amounted to a small percentage of total drugmaker revenue, a hospital-funded study found.

340B Small Share of Drugmaker Revenue, Says Hospital-Backed Report

March 14, 2024 Rich Daly, Editor in Chief Views

Despite the increase in the amount of 340B program drug discounts, those only amounted to 3.1% of global and 7% [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!